Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18
Top Cited Papers
- 1 April 2012
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (4) , 322.e1-322.e5
- https://doi.org/10.1016/j.ajog.2012.01.029
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation studyGenetics in Medicine, 2011
- Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical settingAmerican Journal of Obstetrics and Gynecology, 2011
- Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity studyBMJ, 2011
- Screening for fetal aneuploidies at 11 to 13 weeksPrenatal Diagnosis, 2011
- Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasmaProceedings of the National Academy of Sciences, 2008
- Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodProceedings of the National Academy of Sciences, 2008
- Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free -hCG and pregnancy-associated plasma protein-AHuman Reproduction, 2008
- Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 2004
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- Presence of fetal DNA in maternal plasma and serumThe Lancet, 1997